Skip to main content
SpringerLink
Log in

Impact of venous thromboembolism on survival in patients with advanced cancer: an unmet clinical need

  • IM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sorensen HT, Mellemkjaer L, Olsen JH et al (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850

    Article  CAS  PubMed  Google Scholar 

  2. Khorana AA, Rosenblatt JD, Sahasrabudhe DM et al (2003) A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther 10:251–259

    Article  CAS  PubMed  Google Scholar 

  3. Komrokji RS, Uppal NP, Khorana AA et al (2006) Venous thromboembolism in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 47:1029–1033

    Article  PubMed  Google Scholar 

  4. Nicolaides AN, Kakkar VV, Field ES (1973) Origin of deep vein thrombosis of the leg. Bull Soc Int Chir 32:101–106

    CAS  PubMed  Google Scholar 

  5. Sandler DA, Martin JF (1989) Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 82:203–205

    CAS  PubMed Central  PubMed  Google Scholar 

  6. Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978–981

    Article  CAS  PubMed  Google Scholar 

  7. den Exter PL, Hooijer J, Dekkers OM et al (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 29:2405–2409

    Article  Google Scholar 

  8. Ray-Coquard I, Ghesquiere H, Bachelot T et al (2001) Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas. Br J Cancer 85:816–822

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Giantonio BJ, Catalano PJ, Meropol NJ et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539–1544

    Article  CAS  PubMed  Google Scholar 

  10. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  CAS  PubMed  Google Scholar 

  11. Katopodis O, Ross P, Norman AR et al (2004) Sixty-day all-cause mortality rates in patients treated for gastrointestinal cancers, in randomised trials, at the Royal Marsden Hospital. Eur J Cancer 40:2230–2236

    Article  PubMed  Google Scholar 

  12. Khorana AA, Francis CW, Culakova E et al (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632–634

    Article  CAS  PubMed  Google Scholar 

  13. Kuderer NM, Khorana AA, Francis CW et al (2013) Risk score for venous thromboembolism (VTE) in ambulatory patients: impact of cancer type and risk score on VTE incidence, early mortality, and progression-free survival. Blood 122:3597

    Google Scholar 

  14. Kuderer NM, Khorana AA, Lyman GH et al (2007) A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer 110:1149–1161

    Article  CAS  PubMed  Google Scholar 

  15. Agnelli G, George DJ, Kakkar AK et al (2012) Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 366:601–609

    Article  CAS  PubMed  Google Scholar 

  16. Agnelli G, Gussoni G, Bianchini C et al (2009) Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 10:943–949

    Article  CAS  PubMed  Google Scholar 

  17. Maraveyas A, Waters J, Roy R et al (2012) Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer. Eur J Cancer 48:1283–1292

    Article  CAS  PubMed  Google Scholar 

  18. Lyman GH, Khorana AA, Kuderer NM et al (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189–2204

    Article  CAS  PubMed  Google Scholar 

  19. Lyman GH, Eckert L, Wang Y et al (2013) Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist 18:1321–1329

    Article  PubMed  Google Scholar 

  20. Agnelli G, Verso M, Mandala M et al (2013) A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med 1:9 (Published online)

    Google Scholar 

  21. Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 88:15–19

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Campigotto F, Neuberg D, Zwicker JI (2012) Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier. J Thromb Haemost 10:1449–1451

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Public Health Sciences, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center and the University of Washington, 11000 Fairview Ave N, M3-B232, Seattle, WA, 98109-1024, USA

    Gary H. Lyman

Authors
  1. Gary H. Lyman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary H. Lyman.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lyman, G.H. Impact of venous thromboembolism on survival in patients with advanced cancer: an unmet clinical need. Intern Emerg Med 9, 497–499 (2014). https://doi.org/10.1007/s11739-014-1087-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-014-1087-2

Keywords

Search

Navigation